257 related articles for article (PubMed ID: 36574857)
1. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
2. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
4. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
5. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the "microworld" age.
Wang AJ; Song D; Hong YM; Liu NN
Mol Omics; 2023 May; 19(4):283-296. PubMed ID: 36916422
[TBL] [Abstract][Full Text] [Related]
7. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
8. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
9. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
10. Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer.
Bisht V; Nash K; Xu Y; Agarwal P; Bosch S; Gkoutos GV; Acharjee A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071236
[TBL] [Abstract][Full Text] [Related]
11. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
12. Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study.
Khattab RH; Abo-Hammam RH; Salah M; Hanora AM; Shabayek S; Zakeer S
BMC Microbiol; 2023 Aug; 23(1):238. PubMed ID: 37644393
[TBL] [Abstract][Full Text] [Related]
13. Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer.
Sun XZ; Zhao DY; Zhou YC; Wang QQ; Qin G; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7173-7190. PubMed ID: 33362375
[TBL] [Abstract][Full Text] [Related]
14. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
[TBL] [Abstract][Full Text] [Related]
15. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of the mouse fecal microbiome and metabolome reveal dynamic phenotypes in the development of colorectal cancer.
Liu J; Qi M; Qiu C; Wang F; Xie S; Zhao J; Wu J; Song X
Front Microbiol; 2022; 13():1021325. PubMed ID: 36246263
[TBL] [Abstract][Full Text] [Related]
17. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
[TBL] [Abstract][Full Text] [Related]
18. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
[TBL] [Abstract][Full Text] [Related]
19. BRAF
Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
